Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

906
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
906
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

488
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
488
Drug Dependence01:17

Drug Dependence

1.4K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.4K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.7K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.1K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.4K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Behavioral differences in cooperation between patients with schizophrenia and control participants.

Scientific reports·2026
Same author

WADD-SEPD Consensus on Psychological Treatment of Dual Disorders II: Neurodevelopmental, Anxiety, Post-Traumatic Stress, Somatic Symptom, Eating, and Personality Disorders and Recommendations for Future Research.

Journal of clinical medicine·2026
Same author

WADD-SEPD Consensus on Psychological Treatment of Dual Disorders I: General Recommendations, Most Used Therapies, and Severe Mental Disorders.

Journal of clinical medicine·2026
Same author

Impact of childhood trauma and parental socialization on at-risk mental state in non-clinical adolescents.

World journal of psychiatry·2025
Same author

Randomised controlled trial of clozapine in resistant schizophrenia and schizoaffective disorder.

Journal of psychopharmacology (Oxford, England)·2025
Same author

Effect of basic cardiopulmonary resuscitation training on the knowledge and attitudes of professional football players and coaches.

SAGE open medicine·2025

Related Experiment Video

Updated: Nov 15, 2025

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

10.8K

Prepulse Inhibition in Cocaine Addiction and Dual Pathologies.

Isis Gil-Miravet1,2, Alejandro Fuertes-Saiz1,3, Ana Benito1,4

  • 1TXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón, Spain.

Brain Sciences
|March 6, 2021
PubMed
Summary

Prepulse inhibition (PPI) was higher in cocaine-related disorder (CRD) patients, but it is not a reliable differentiator for dual diagnoses like schizophrenia or antisocial personality disorder.

Keywords:
antisocial personality disordercocaine-related disorderdual diagnosisprepulse inhibitionpsychopathyschizophrenia

More Related Videos

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

14.7K
Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

2.8K

Related Experiment Videos

Last Updated: Nov 15, 2025

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
07:51

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder

Published on: June 18, 2018

10.8K
Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

14.7K
Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

2.8K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Cocaine addiction often co-occurs with psychiatric disorders, notably schizophrenia and antisocial personality disorder.
  • Pre-pulse inhibition (PPI) has been explored as a potential biomarker to differentiate these conditions.
  • Understanding these comorbidities is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate prepulse inhibition (PPI) and patient phenotypes in individuals with cocaine-related disorder (CRD) and comorbid schizophrenia or antisocial personality disorder.
  • To assess the utility of PPI as a discriminating factor among these diagnostic groups.

Main Methods:

  • A cohort of 74 men (aged 18-60) was divided into four groups: CRD, CRD with schizophrenia, CRD with antisocial personality disorder, and a control group.
  • Pre-pulse inhibition (PPI) and other vulnerability factors were assessed using various scales.
  • Discriminant function analysis was employed to predict group membership.

Main Results:

  • Prepulse inhibition (PPI) was significantly higher in the CRD group at 30 ms (p = 0.038).
  • A discriminant model using Hare Psychopathy Checklist Revised score, reward sensitivity, and PPI at 30 ms achieved 79.7% accuracy in classifying patients.
  • Despite observed differences, PPI showed limited utility in distinguishing between specific diagnostic groups.

Conclusions:

  • Prepulse inhibition (PPI) may serve as a non-specific endophenotype in certain mental disorders, including dual diagnoses involving cocaine addiction.
  • While PPI differs across groups, its discriminative power for specific comorbid psychiatric conditions in CRD patients is limited.
  • Further research is needed to identify reliable biomarkers for differentiating complex psychiatric comorbidities in addiction.